190 related articles for article (PubMed ID: 7882365)
21. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
Chavany C; Connell Y; Neckers L
Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
[TBL] [Abstract][Full Text] [Related]
22. Effects of c-myc oncogene modulation on drug resistance in human small cell lung carcinoma cell lines.
Van Waardenburg RC; Prins J; Meijer C; Uges DR; De Vries EG; Mulder NH
Anticancer Res; 1996; 16(4A):1963-70. PubMed ID: 8712728
[TBL] [Abstract][Full Text] [Related]
23. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
24. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene.
Pape KA; Floyd-Smith G
Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625
[TBL] [Abstract][Full Text] [Related]
25. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
Yu BW; Nguyen D; Anderson S; Allegra CA
Anticancer Res; 1997; 17(6D):4407-13. PubMed ID: 9494542
[TBL] [Abstract][Full Text] [Related]
26. [The effects of RA538 and antisense c-myc on cervical cancer cell lines with high expression of bcl-2 gene].
Chen J; Lin C; Deng Y
Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):279-82. PubMed ID: 11778549
[TBL] [Abstract][Full Text] [Related]
27. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
28. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides.
Mizushima Y; Kashii T; Kobayashi M
Anticancer Res; 1995; 15(1):37-43. PubMed ID: 7733638
[TBL] [Abstract][Full Text] [Related]
29. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
30. Expression of the L-myc gene is under positive control by short-lived proteins.
Saksela K
Oncogene; 1987; 1(3):291-6. PubMed ID: 2838780
[TBL] [Abstract][Full Text] [Related]
31. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T
Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350
[TBL] [Abstract][Full Text] [Related]
32. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
33. A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation.
Capeáns C; Piñeiro A; Domínguez F; Loidi L; Buceta M; Carneiro C; Garcia-Caballero T; Sanchez-Salorio M
Exp Eye Res; 1998 May; 66(5):581-9. PubMed ID: 9628805
[TBL] [Abstract][Full Text] [Related]
34. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
Abdel-Mageed A; Agrawal KC
Cancer Gene Ther; 1997; 4(3):199-207. PubMed ID: 9171939
[TBL] [Abstract][Full Text] [Related]
35. Rearrangement and co-amplification of L-myc and rlf in primary lung cancer.
Mäkelä TP; Shiraishi M; Borrello MG; Sekiya T; Alitalo K
Oncogene; 1992 Mar; 7(3):405-9. PubMed ID: 1312699
[TBL] [Abstract][Full Text] [Related]
36. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line.
Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M
Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533
[TBL] [Abstract][Full Text] [Related]
37. Antigene and antiproliferative effects of a c-myc-targeting phosphorothioate triple helix-forming oligonucleotide in human leukemia cells.
McGuffie EM; Pacheco D; Carbone GM; Catapano CV
Cancer Res; 2000 Jul; 60(14):3790-9. PubMed ID: 10919652
[TBL] [Abstract][Full Text] [Related]
38. A study of myc-related gene expression in small cell lung cancer by in situ hybridization.
Gu J; Linnoila RI; Seibel NL; Gazdar AF; Minna JD; Brooks BJ; Hollis GF; Kirsch IR
Am J Pathol; 1988 Jul; 132(1):13-7. PubMed ID: 2456019
[TBL] [Abstract][Full Text] [Related]
39. Recombinant antisense C-myc adenovirus increase in vitro sensitivity of osteosarcoma MG-63 cells to cisplatin.
Xie XK; Yang DS; Ye ZM; Tao HM
Cancer Invest; 2006 Feb; 24(1):1-8. PubMed ID: 16466985
[TBL] [Abstract][Full Text] [Related]
40. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion].
Zheng JM; Wang DK; Jiang HM
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1537-9. PubMed ID: 16361157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
